As a government price-setting formula, the same arithmetic has produced the opposite result.
|Articles|January 10, 2005
Feds approve highway signs for pharmacies
While not as clever as the amusing Burma Shave signs, exit signs alerting drivers to nearby pharmacies may soon sprout up on America's roadways in states that adopt new regulations from the Federal Highway Administration (FHWA).
Advertisement
Advertisement
Related to this article
Orforglipron lowered A1C and body weight more than oral semaglutide 25 mg at 52 weeks, but the estimate comes from an indirect comparison.
Brian Smith, PharmD, explains how direct-to-consumer GLP-1 pathways broaden initial access but endanger long-term patient adherence.
Pharmacists face burnout and financial strain as PBMs take big cuts, prompting urgent calls for reform to protect patient care and community pharmacies.
What pharmacy technicians say would actually make them feel seen on World Pharmacy Technician Day, and the other 364 days of the year.
The analysis is not a head-to-head trial, and the weight loss gap reached statistical significance under 1 of 2 estimands.
A 1.6-million-birth analysis finds that adoption of a 2016 trial's antibiotic protocol climbed sharply in US hospitals, with a drop in infection rates.
New findings suggest semaglutide's benefits may extend well beyond diabetes and weight loss and into airway disease and mood disorders.
Advertisement
Advertisement
Trending on Drug Topics
1
Orforglipron Shows Greater A1C, Weight Reduction Than Oral Semaglutide
2
Technicians Aren't Asking for a Party
3
Burnout and PBMs Remain Barriers for Community Pharmacists
4
Indirect Comparison Links Tirzepatide to Greater Weight Loss Than Semaglutide
5